(Q27851787)
Statements
1 reference
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer (English)
1 reference
Francesco Galimi
1 reference
November 2011
0 references
1
0 references
6
0 references
508-23
0 references